TY  - JOUR
AU  - Vázquez Morón, Juan María
AU  - Rodríguez Moncada, Rafael
AU  - Pallarés Manrique, Héctor
PY  - 2019
DO  - 10.17235/reed.2019.5802/2018
SN  - 1130-0108
UR  - http://hdl.handle.net/10668/14283
T2  - Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva
AB  - Secondary non-response to biological treatments tends to occur in a high number of patients who undergo treatment with antiTNF, and it has also been observed in patients treated with vedolizumab or ustekinumab. The initial rescue guideline recommends...
LA  - en
KW  - Crohn Disease
KW  - Drug Administration Schedule
KW  - Female
KW  - Humans
KW  - Ileitis
KW  - Induction Chemotherapy
KW  - Maintenance Chemotherapy
KW  - Middle Aged
KW  - Retreatment
KW  - Ustekinumab
TI  - Intravenous ustekinumab reinduction as a Crohn's disease rescue strategy following a secondary non-response.
TY  - research article
VL  - 111
ER  -